Prostate Cancer News

HealthDay - TUESDAY, Nov. 20 (HealthDay News) -- In recent years, doctors have learned that they need to adjust the results of blood tests to properly diagnose prostate cancer in obese men, but now researchers think they know why.

Reuters - Doctors reading the results of a blood test widely used to screen for prostate cancer can be fooled into thinking obese men are disease-free, researchers said on Tuesday.

HealthDay - WEDNESDAY, Nov. 14 (HealthDay News) -- A highly targeted biologic drug called cetuximab (Erbitux) is the first to extend the survival of patients with advanced colon cancer who have otherwise proved resistant to conventional chemotherapy, Canadian researchers confirmed.

HealthDay - TUESDAY, Nov. 13 (HealthDay News) -- In mice, a low-carbohydrate diet slowed prostate tumor growth, possibly because fewer carbohydrates leads to a drop in insulin production, U.S. researchers say.

HealthDay - MONDAY, Nov. 12 (HealthDay News) -- In another sign that too much weight spells health problems, new research suggests that fat men are twice as likely to die after being diagnosed with prostate cancer than men of normal weight.

HealthDay - WEDNESDAY, Nov. 7 (HealthDay News) -- In mice, an investigational agent called VN/14-1 proved effective in treating human prostate cancer, say researchers at the University of Maryland in Baltimore.

Reuters - Drugmaker Novacea Inc ended a late-stage trial of its prostate cancer drug Asentar, after a treatment arm containing the drug showed a higher death rate compared with the standard care, driving shares down more than 69 percent to a lifetime low.

HealthDay - FRIDAY, Nov. 2 (HealthDay News) -- Radiation seed implants, known as brachytherapy, are just as effective for treating prostate cancer in men 60 and younger as they are for older men, a new study finds.

HealthDay - FRIDAY, Nov. 2 (HealthDay News) -- A variant of a gene that doubles the risk of prostate cancer in black men has been identified, and researchers say the discovery could lead to new treatments.

HealthDay - WEDNESDAY, Oct. 31 (HealthDay News) -- Men who were taking statins to lower their cholesterol had a 10 percent greater chance of being cured of prostate cancer by radiation therapy 10 years after diagnosis, a new study finds.

HealthDay - TUESDAY, Oct. 30 (HealthDay News) -- Among prostate cancer patients undergoing a high-tech form of radiation therapy, exposure to a higher amount of radiation over a shorter time span poses no added risk for impaired sexual function, new research reveals.

HealthDay - MONDAY, Oct. 29 (HealthDay News) High-dose precision radiation therapy doesn't harm the sexual function of prostate cancer patients, U.S. researchers say.

HealthDay - WEDNESDAY, Oct. 24 (HealthDay News) -- The addition of the chemotherapy drug, docetaxel, to the standard two-drug regimen used for head and neck cancers improved the efficacy of the treatment while reducing the toxicity, two new studies report.

Reuters - An analysis of the results of several studies confirm previous reports suggesting that chemotherapy offers little or no survival benefits for young women with estrogen receptor (ER)-positive breast cancers and, if given, it should not be the sole second-phase, or "adjuvant" therapy.

HealthDay - TUESDAY, Oct. 9 (HealthDay News) -- Prostate cancer patients receiving androgen-deprivation therapy, a common form of hormone treatment proven to slow tumor growth and prolong life, may face a nearly threefold higher risk of dying from heart disease, a new study suggests.

Prostate cancer patients receiving androgen-deprivation therapy, a common form of hormone treatment proven to slow tumor growth and prolong life, may face a nearly threefold higher risk of dying from heart disease, a new study suggests.

HealthDay - MONDAY, Oct. 8 (HealthDay News) -- Surgery may offer the best chance of long-term survival for prostate cancer patients, a Swiss study suggests.

Surgery may offer the best chance of long-term survival for prostate cancer patients, a Swiss study suggests.

Reuters - Men have the best chance of surviving prostate cancer in the long run if the gland is removed, particularly if they are younger or the cancer is aggressive, a study said on Monday.

HealthDay - SUNDAY, Oct. 7 (HealthDay News) -- For several years, doctors have debated the value of the prostate-specific antigen test to determine a man's risk for prostate cancer.